According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

NEW YORK, NY / ACCESS Newswire / March 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...

Yesterday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision vacating the Patent Trial and ...

Merck & Co. shows strong financial health ... has mostly increased over the past five years. GMP fell in 2020, but rebounded strongly in 2021 and reached its highest level in 2023 at 73.17%.

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... a spike in investor interest around the beginning of 2020, which was dubbed the “psychedelic renaissance.” ...

Some of you know me from past interactions, I'm sure. But for those who don't, I joined Merck Healthcare at the end of 2020 as Global Head of Development and have served as Global Head of R&D and ...